综合功能基因组学分析确定了血管疾病的类基因
Charles U Solomon1,2,3, David G McVey1,2,3, Catherine Andreadi1,2,3
1Division of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Nature communications
|February 5, 2026
概括
研究人员确定了影响冠状动脉疾病和高血压等血管疾病的关键基因. 这些发现通过了解这些疾病的遗传基础,揭示了新的治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 心血管疾病 心血管疾病
- 基因组学就是基因组学.
背景情况:
- 冠状动脉疾病,高血压,中风和腹腔大动脉动脉瘤等血管疾病已知存在遗传联系.
- 全基因组关联研究 (GWAS) 已经确定了与这些疾病相关的众多遗传位置.
- 在这些位置确定致病基因对于理解疾病机制和开发疗法至关重要.
研究的目的:
- 通过整合功能基因组学识别潜在的常见血管疾病的可能因果基因.
- 研究这些基因在血管光滑肌肉细胞行为和疾病发病过程中的作用.
- 探索已识别的基因对多种血管疾病的类效应.
主要方法:
- 综合功能基因组学分析与血管疾病相关的GWAS位点.
- 聚合了CRISPR淘汰屏幕,以评估血管光滑肌细胞中的基因功能.
- 在体内验证实验,包括在小鼠中进行基因淘汰,以确认功能效应.
主要成果:
- 确定了一组可能导致血管疾病的致病基因组,其中一些显示有性效应.
- 克里斯普尔屏幕显示,许多已识别的基因会影响血管光滑肌肉细胞的行为.
- 验证证实FES,BCAR1,CARF和SMARCA4影响血管细胞功能.
- 鉴定出FES是冠状动脉疾病和高血压的性基因,调节血管改造基因.
- 费斯淘汰赛小鼠表现出加速动脉样硬化和高血压.
结论:
- 这项研究提供了关于血管疾病遗传结构的见解.
- 已识别的基因,特别是FES,代表了心血管疾病的潜在治疗点.
- 了解血管光滑肌细胞中的基因功能是解读疾病机制的关键.
相关概念视频
Genome Size and the Evolution of New Genes
9.2K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.2K
Genome Size and the Evolution of New Genes
3.5K
3.5K
Genomics
40.8K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.8K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Gene Families
10.0K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Export of Mitochondrial and Chloroplast Genes
4.2K
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K


